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Abstract
Background: Depressive symptomatology may act as a barrier to enhance physical activity. This phenomenon is
predominantly found in patients with an established cardiovascular disease (CVD) and in female patients. This cross-
sectional study investigated (1) the association between symptoms of depression and physical inactivity, and (2) whether
this association is different between primary and secondary prevention patients, and between men and women.
Methods: The study design concerns a secondary analysis of baseline data from a randomized clinical trial, including
primary and secondary prevention patients (n = 2184; mean age 71.6 ± 8.94), from 34 general practitioner panels. The
Rapid Assessment of Physical Activity questionnaire (RAPA) was used to measure patient reported activity levels.
Symptoms of depression were determined using the Patient Health Questionnaire (PHQ-9). Multilevel linear regression
analysis was used to explore the association between symptoms of depression and physical activity while adjusting for
confounders. Gender and whether or not having a CVD were considered as potential effect modifiers for the association
between symptoms of depression and inactivity.
Results: Symptoms of depression were associated with lower levels of physical activity. This association was neither
different for men and women nor for primary and secondary prevention patients.
Conclusion: In primary care patients’ symptoms of depression were associated with physical inactivity. This association
was not modified by gender or the presence of a CVD. Future research should focus on lifestyle interventions aiming at
the increase of physical activity levels, while emphasizing on improving symptoms of depression in men, women, and
patients both with and without a history of CVD.
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Background
Regular physical activity reduces the progression of ath-
erosclerosis, and consequently optimizes the cardiovas-
cular risk profile, and thereby decreases the incidence of
cardiovascular events [1]. Exercise capacity is mentioned
as one of the strongest modifiable predictors of mortality
among patients at risk for developing a cardiovascular
disease (CVD) [2]. Despite this well-documented effect,
exercise activity is limited among many patients at high
cardiovascular risk [3, 4]. Stimulating physical activity is
therefore a core component of cardiovascular risk man-
agement (CVRM) in primary care [5]. However, to tailor
CVRM interventions to individual patients’ needs it is
critical to identify patient characteristics that are associated
with physical inactivity. Patient characteristics such as
depressive symptomatology [6–8], female gender [9, 10],
and suffering a CVD [11] have been found to deteriorate
physical activity levels.
Depressive symptomatology may impede the success-
ful stimulation of physical activity and patients’ efforts to
improve lifestyle in CVD [6–8]. On the other hand,
symptoms of depression can be reduced by increasing
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: Retze.Achttien@radboudumc.nl
1Radboud Institute for Health Sciences, IQ healthcare, Radboud university
medical center, Geert Grooteplein 21, 6500, HB, Nijmegen, The Netherlands
Full list of author information is available at the end of the article
Achttien et al. BMC Cardiovascular Disorders           (2019) 19:95 
https://doi.org/10.1186/s12872-019-1065-8
physical activity levels among CVD patients [12–14].
Depressive symptomatology predicts the incidence of
CVD, worsens its prognosis, and is mentioned as an
independent risk factor for mortality in CVD patients
[15–17]. The prevalence of depressive symptomatology
increases with age [11, 18], smoking status [18, 19], and
is more prevalent in women compared to men [9, 10].
Female gender is, independent from experiencing symp-
toms of depression, also associated with lower activity
levels [20, 21]. This might, for instance, be caused by
lower perceived self-efficacy and self-management levels
in women [22]. Additionally, women experience a CVD
at an older age than men, and consequently suffer co-
morbidity more frequently, resulting in lower activity
levels [23–25]. More attention for female gender during
CVRM in clinical practice is therefore advocated in the
literature [9, 10].
Symptoms of depression and consequently lower activ-
ity levels are also more frequently reported after a
cardiovascular event [20, 26, 27]. Research demonstrat-
ing this relationship between depression and inactivity is
predominantly conducted during or after (cardiac) re-
habilitation in patients with an established CVD (sec-
ondary prevention patients) [20]. It may be assumed that
this relationship also exists in primary prevention pa-
tients (patients at high cardiovascular risk without an
established CVD), but data to support this hypothesis
are lacking. Yet, insight into possible differences in the
association between symptoms of depression and phys-
ical inactivity among primary and secondary prevention
population might be important for tailoring CVRM to
these respective populations [28].
To further explore the association between symptoms of
depression and physical inactivity we used baseline data
from a large clustered randomized clinical trial (RCT)
conducted in primary care patients in the Netherlands
[28]. The present study aims to investigate (1) the associ-
ation between symptoms of depression and physical
inactivity, and (2) whether this association is different be-
tween primary and secondary prevention patients, and be-
tween men and women. These analyses should contribute
to our understanding about how to tailor patient-specific
lifestyle interventions aiming at a healthy and physically
active lifestyle, offered during CVRM in primary care.
Methods
Study design
The study design concerns a cross-sectional secondary
analysis of baseline data from a clustered RCT [28]. The
RCT was part of the international Tailored Implementa-
tion for Chronic Diseases (TICD) project. This project
developed and tested programs to improve healthcare
for patients with chronic diseases in five European coun-
tries, and examined methods for tailoring such programs
to target groups and settings [29]. The Medical Ethics
committee Arnhem-Nijmegen, the Netherlands, waived
approval (number 2013/229) for the RCT [30]. The
declaration of Helsinki was followed. In our study, we
followed the STrengthening the Reporting of OBserva-
tional studies in Epidemiology (STROBE) statement to
report our cross-sectional study [31].
Setting
A random sample of 1600 general practices in seven
geographical areas in the Netherlands was invited to par-
ticipate in the RCT [28], resulting in a sample of 34
practices and 2184 patients that were included in our
study. Baseline data, used in our study, were collected by
the general practitioner (GP) or a nurse practitioner in
the years 2013 and 2014. GP practices were only invited
to participate if a practice assistant was working in the
practice with CVRM in the portfolio.
Participants
All patients were 18 years or older and were able to pro-
vide informed consent. Exclusion criteria were diabetes
mellitus, pregnancy and lactation, terminal illness, cogni-
tive impairment, and insufficient mastery of the Dutch
language hindering reading and answering the question-
naires. We included the baseline data from a RCT [28]
that focussed on CVRM for primary and secondary
prevention patients. Primary prevention patients had an
estimated 10-year risk score of 20% or higher for mor-
bidity and mortality due to CVD. Secondary prevention
patients had a cardiovascular event (predominantly
coronary artery disease or less frequently a stroke) in
history or suffered from a chronic heart disease or
peripheral arterial disease. Patient selection was based
on the following International Classification of Primary
Care (ICPC) codes: K74-K76, K85-K92, K99.1, and T93.
Variables
The outcome variable was the degree of physical activity
measured by the patient reported Rapid Assessment of
Physical Activity questionnaire (RAPA) [32]. The pre-
dictor variable was symptoms of depression measured
by the Patient Health Questionnaire-9 (PHQ-9) [33].
Gender and whether or not suffering a CVD were
considered potential effect modifiers for the association
between symptoms of depression and inactivity. The
experienced degree of control on own health status,
measured using the Patient Activation Measure ques-
tionnaire (PAM) [34], age, and smoking status were con-
sidered as potential confounders.
Data sources and measurements
Data were collected using structured questionnaires.
Questionnaires were sent by mail to all patients and
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returned by mail as well. Data collection was performed
equally in primary and secondary prevention patients.
Study size
The sample size that was used in the RCT [28] on which
we focused was based on a sample size calculation for the
cluster randomized trial [30]. The calculation indicated
that 450 patients per group (primary or secondary preven-
tion) would be needed for the RCT (15 primary and 15
secondary prevention patients per cluster, sampled in 30
practices). The patient response to participate in the RCT
was 41.8% of the invited patients at baseline [28].
Quantitative variables
All patients filled out the RAPA, PHQ-9, PAM and a smok-
ing questionnaire. The RAPA (9-items) is a valid measure
of physical activity for use in clinical practice [32]. RAPA
evaluates a wide range of physical activity levels, from sed-
entary to vigorous activity, as well as strength and flexibility
training [35]. Each question has a ‘Yes’ or ‘No’ option. The
score ranges from 1 to 7; a score of 6–7 points is
considered “active”, 4–5 points as “suboptimal active”,
and ≤ 3 points is defined as “sedentary” to “under-active
regular-light activities”. Missing values were only consid-
ered as such if no questions were filled in. In the data-ana-
lysis, we used the RAPA as a continuous score.
The PHQ-9 is a validated depression module for pri-
mary care, which scores each of the nine Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) cri-
teria as “0” (not at all) to “3” (nearly every day), with a
total score ranging from 0 to 27 points [32]. The total
score can also be categorized in 5 severity levels; 0–4
none, 5–9 mild, 10–14 moderate, 15–19 moderately
severe, and 20–27 severe symptoms of depression. The
total score on the PHQ-9 was used as a continuous
value in the statistical analysis.
The PAM is a valid and reliable instrument assessing
patients’ activation measure [34]. The PAM survey mea-
sures patients on a 13–52 scale, revealing insight into an
array of health-related characteristics (attitudes, motiva-
tors, behaviors, and outcomes). In case 1 or 2 separate
questions were not answered (missing), the total PAM
score was subsequently divided by 12 or 13 and multi-
plied by 13. The PAM was excluded from analysis if
fewer than 11 out of 13 questions were answered. This
strategy was in accordance with the guideline for inter-
pretation of the questionnaire [34].
The smoking status was derived from the first question
of a standardized questionnaire on smoking habits [36].
There were 4 possible answers options: “Yes I smoke”,
“No I quite last 6 months”, “No I quite more than 6
months ago”, or “No I never smoked”. We dichotomized
this into Yes or No in the analysis. The covariate age was
used as a continuous variable in the analysis.
Statistical methods
Data analysis was performed using SPSS (version 23,
IBM Corp.) Data were described using means, standard
deviations, numbers, and percentages. Patient character-
istics and the outcome of (completed) questionnaires
were presented for the total study population. Outcomes
were presented on a dichotomous or continuous scale.
First, independent sample T-tests and/ or Chi-square
tests were used to compare the outcome variable, the
predictor, and potential confounders between primary
and secondary prevention patients, and between male
and female patients. Second, the assumptions for multi-
level linear regression analyses (i.e. linear relationship
between the independent and dependent variables,
multivariate normality, no or little multicollinearity, and
homoscedasticity) were checked [37]. Then, multilevel lin-
ear regression analysis (95% confidence intervals (CIs)),
using random slopes and intercepts, was performed to de-
termine the association between symptoms of depression
and physical inactivity. We adjusted for the potential con-
founders; score on the PAM questionnaire, age and smok-
ing, gender and whether or not suffering a CVD. Third,
we explored if the association between symptoms of
depression and physical inactivity was different between
primary and secondary prevention patients, and between
men and women, by adding the interaction terms (primary/
secondary prevention group*PHQ-9 and gender*PHQ-9
respectively) to separate models. A p value < 0.05 was
considered as statistically significant.
Results
Participants and descriptive data
Table 1 presents the descriptive statistics and responses
to the questionnaires.
In total, 2184 patients were included in our study
(1250 primary and 934 secondary prevention patients),
consisting of 761 female patients and 1423 male patient.
The high-risk population consisted of 33% (mean age
75.7 ± 7.0) female patients and in the CVD population
38% (mean age 68.8 ± 13.1). Primary prevention patients
were significantly older than secondary prevention pa-
tients (p < 0.05; 73.99 ± 6.99 vs 68.50 ± 11.73). In total,
110 (5%) patients filled out the RAPA inadequately. For
the PHQ-9, PAM and smoking status, the non-response
was as follows: 76 (3,4%), 68 (3,1%), and 57 (2,6%).
Outcome data
Female patients in the primary prevention group scored
on average 4.40 (±1.62) points on the RAPA and in the
secondary prevention group 4.61 (±1.55) points. This dif-
ference is statistically significant (p < 0.05). Male patients
were in both groups physically more active (p < 0.01)
compared to female patients (primary prevention group
5.01 ± 1.54 vs 4.4 ± 1.62 and secondary prevention
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group 5.02 ± 1.58 vs 4.61 ± 1.55, P < 0.01). In the primary
and secondary prevention group, about 50% of the pa-
tients scored “active” on the RAPA (6–7 points), 25%
scored “less than suboptimal active” (4–5 points), and 25%
scored “sedentary” to “under-active regular-light activities”
(1–3 points).
Most patients in this study did not report symptoms
of depression (81.4% in the primary prevention group
and 69.9% in the secondary prevention group). Mild and
moderate symptoms of depression were more frequently
reported in the secondary prevention group compared
to the primary prevention group (mild symptoms of de-
pression; 11,3% vs 19.0% and moderate symptoms of de-
pression 2,8% vs 5.5%, p < 0.01). Reported symptoms of
depression were significantly higher in patients suffering a
CVD (women: 4.23 ± 4.48, men 2.57 ± 3.48, p < 0.01) com-
pared to primary prevention patients (women: 2.67 ± 3.35,
men 1.78 ± 3.08, p < 0.01).
In the secondary prevention group, both female and
male patients were more often reported to be a smoker
compared to the primary prevention group. The primary
prevention group reported lower scores on the PAM
compared to secondary prevention patients (36.27 ± 8.55
vs 37.68 ± 7.63, p < 0.01). There was no difference in
PAM score between women and men.
Main results
Assumptions for multilevel linear regression analyses
were not violated and no effect for clustering was found
(ICC = 0.02). Table 2 presents the multilevel linear re-
gression analyses concerning the association between
symptoms of depression and physical inactivity (using
the RAPA as a continuous variable), adjusted for con-
founders. There was a significant association (p < 0.01)
between symptoms of depression and physical inactivity,
indicating that a 1-point increase on the PHQ-9 ques-
tionnaire is associated with a decrease of 0.06 on the
RAPA. The association between symptoms of depression
and physical inactivity was neither modified by the inter-
action term primary/secondary prevention group*PHQ-9
(p = 0.47: Table 2, model 2) nor by the interaction term
gender*PHQ-9 (p = 0.44: Table 2, model 3).
Discussion
Key results
The aim of this study was to investigate (1) the associ-
ation between symptoms of depression and physical in-
activity, and (2) if this association is different between
primary and secondary prevention patients, and between
men and women. Our results revealed that depression
was associated with physical inactivity in both primary
Table 1 Descriptive characteristics of the study population
Patient group
Primary prevention patients Secondary prevention patients
Female
(n = 407)
Male
(n = 843)
Total
(n = 1250)
Female
(n = 354)
Male
(n = 580)
Total
(n = 934)
Age in years, mean, SD 75.74 ± 7.10 73.15 ± 6.79 73.99 ± 6.99 68.83 ± 13.11 68.31 ± 10.80 68.50 ± 11.73
RAPA, mean, SD 4.4 ± 1.62 5.01 ± 1.54 4.82 ± 1.59 4.61 ± 1.55 5.02 ± 1.58 4.87 ± 1.58
Active (RAPA 6–7 points), n, (%) 151 (37.1%) 430 (51.0%) 581(46.5%) 137 (38.7%) 299 (51.6%) 436 (46.7%)
Suboptimal (RAPA 4–5 points), n, (%) 97 (23.8%) 205 (24.3%) 302 (24.2%) 97 (27.4%) 132 (22.8%) 229 (24.5%)
Underactive (RAPA≤3 points), n, (%) 129 (31.8%) 172 (20.4%) 301 (24.1%) 98 (27.7%) 127 (21.9%) 225 (24.1%)
Missing, n, (%) 30 (7.4%) 36 (4.3%) 66 (5.3%) 22 (6.2%) 22 (3.8%) 44 (4.7%)
PHQ-9, mean, SD 2.67 ± 3.35 1.78 ± 3.08 2.05 ± 3.19 4.23 ± 4.48 2.57 ± 3.49 3.18 ± 3.96
No symptoms of depression (0–4), n, (%) 298 (73.2%) 719 (85.3%) 1017 (81.4%) 208 (58.8%) 445 (76.7%) 653 (69.9%)
Mild symptoms of depression (5–9), n, (%) 64 (15.7%) 77 (9.1%) 141 (11.3%) 93 (26.3%) 84 (14.5%) 177 (19.0%)
Moderate symptoms of depression (10–14), n, (%) 13 (3.2%) 22 (2.6%) 35 (2.8%) 26 (7.3%) 25 (4.3%) 51 (5.5%)
Moderately severe symptoms of depression (15–19), n, (%) 7 (1.7%) 3 (0.4%) 10 (0.8%) 10 (2.8%) 4 (0.7%) 14 (1.5%)
Severe symptoms of depression (20–27), n, (%) 0 4 (0.5%) 4 (0.3%) 4 (1.1%) 2 (0.3%) 6 (0.6%)
Missing, n, (%) 25 (6.1%) 18 (2.1%) 43 (3.4%) 13 (3.7%) 20 (3.4%) 33 (3.5%)
PAM, mean, SD 35.31 ± 8.47 36.70 ± 8.55 36.27 ± 8.5 36.41 ± 7.59 38.45 ± 7.56 37.68 ± 7.63
Missing, n, (%) 28 (7.4%) 12 (1.4%) 40 (3.3%) 14 (4.1%) 14 (2.5%) 28 (3.1%)
Smoking status
YES, n, (%) 23 (5.9%) 87 (10.5%) 91.2 (8.8%) 52 (15.2%) 77 (13.6%) 129 (13.8%)
NO, n, (%) 366 (94.1%) 471 (89.5%) 1107 (89.5%) 291 (84.8%) 490 (86.4%) 781 (86.2%)
Missing, n, (%) 18 (4.4%) 15 (1.8%) 33 (2.7%) 11 (3.1%) 13 (2.2%) 24 (2.5%)
RAPA Rapid Assessment of Physical Activity Questionnaire, PHQ-9 Patient Health Questionnaire-9, PAM Patient Activation Measure questionnaire
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and secondary prevention patients in primary care.
However, this association was not modified by gender or
the presence of a CVD.
Strengths and limitations
Patient baseline data (from the RCT [28]) were collected
from GP databases, considering an even distribution of
primary and secondary prevention patients. However, se-
lection bias may have influenced the outcome in our
study. In total 34 GP facilities participated in the RCT,
while 1600 practices were invited to participate [28]. In
the practices, a nurse practitioner had to be employed
who had CVRM in the portfolio. Therefore, it is possible
that predominantly data from higher quality GP prac-
tices were used in our study.
The selection criteria for patients being included in our
study were standardized, using ICPC diagnose codes
(mostly objective criteria). Selection bias may have oc-
curred in the RCT by a low patient response (41.8% at
baseline) to the invitation to participate [28]. It could be,
for example, that patients with no or minor depression
predominately participated in our study. However, this se-
lection bias was probably the same in primary and second-
ary prevention group. Other factors (covariates) associated
with physical activity levels and/ or symptoms of depres-
sion, for which we did not adjust in the analysis, may have
been different between the primary and secondary preven-
tion group. Factors such as personal (scheduling, motiv-
ation), social (family support) and environmental (cost,
access) barriers and biological correlates (body mass
index, physical co-morbidities) may have acted as con-
founders [6, 20, 24, 38]. In particular, the body mass index
might have been a potential confounder, as it has been
reported to be associated with lower activity levels in
depressed patients [39]. We did not correct for the BMI
variable in our model, due to the substantial number of
missing data (77%). This is a limitation of our study.
Validated questionnaires were used in our study. Only
a limited number of patients did not fill out the ques-
tionnaires correctly. We consider this as a strength of
our study. Due to the cross-sectional study design, how-
ever, it is not possible to draw any causal relationship.
This is an important limitation of this study design.
Interpretation
We revealed the association between symptoms of
depression and physical inactivity in a primary care
population consisting of primary and secondary preven-
tion patients. In addition, to our knowledge, this is the
first study that investigates the possible difference in the
association between depression and inactivity between
primary and secondary prevention patients, and between
men and women.
Increased symptoms of depression and consequently
physical inactivity were previously reported in secondary
prevention patients during or after cardiac rehabilitation
[11, 25]. In addition, it was reported that adults with major
depression disorders do have low levels of physical activity
[39]. Moreover, in secondary prevention patients it has
also been found that inactive patients are more often de-
pressed and that the more patients get depressed, the less
active they become [12, 13]. This is in line with our find-
ings in secondary prevention patients, and we also found
that this association exists in primary prevention patients.
It should be noted that our population predominantly had
no (81.4% of the primary and 69.9% of the secondary pre-
vention patients) or only minor symptoms of depression.
The association between depression and physical in-
activity was not always consistently reported. In a narra-
tive review [20] for example, authors concluded that
during cardiac rehabilitation, depression was associated
Table 2 Results of multilevel linear regression analyses presenting the association between symptoms of depression and physical
activity
Model 1
95% C.I.
Model 2
95% C.I.
Model 3
95% C.I.
RAPA (1–7) B Lower Upper P B Lower Upper P B Lower Upper P
PHQ-9 (0–27) −0.06 −0.08 −0.04 < 0.01 −0.08 −0.14 −0.02 0.01 −0.09 −0.15 −0.02 0.01
Gender (M/ F) 0.33 0.18 0.48 < 0.01 0.33 0.18 0.48 < 0.01 0.29 0.10 0.47 < 0.01
Patient group (SP/PP) −0.01 − 0.15 0.14 0.92 −0.05 − 0.22 0.12 0.55 −0.02 − 0.16 0.12 0.82
Age (Y) −0.03 −0.03 − 0.02 < 0.01 − 0.03 −0.04 − 0.02 < 0.01 − 0.03 −0.04 − 0.02 < 0.01
Smoking status (Y/ N) 0.35 0.13 0.57 < 0.01 0.35 0.13 0.56 < 0.01 0.34 0.13 0.56 < 0.01
PAM (0–13) 0.02 0.01 0.03 < 0.01 0.02 0.01 0.03 < 0.01 0.02 0.01 0.03 < 0.01
SP/PP group*PHQ-9 0.01 −0.02 0.05 0.47
Gender*PHQ-9 0.02 −0.02 0.05 0.44
* means SP/ PP group multiplied by PHQ-9
Rapid Assessment of Physical Activity Questionnaire. PHQ9 Patient Health Questionnaire 9, PAM Patient Activation Measure questionnaire score, SP secondary
prevention patients, PP primary prevention patients
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with physical inactivity in 63% of the studies included.
This association was lower (57% of the studies included)
in secondary prevention patients who did not attend a
rehabilitation program [20]. Differences in findings
might be due to the level of symptoms of depression that
patients suffer and the degree of patients’ inactivity. Pa-
tients included in our study had relatively low levels of
symptoms of depression compared to other studies [20].
In the secondary prevention group, this could be the
result of multidisciplinary (cardiac) rehabilitation that
patients may have followed prior to entering our study,
which aims for improving symptoms of depression.
Overall, our study population was also less active com-
pared to patients included in other research [20, 40]. This
could be explained by the fact that we included older
patients, who might suffer more comorbidity and are there-
fore less active [23–25]. On the other hand, aging is re-
ported to be inconsistently associated with lower activity
levels and exercise adherence among secondary prevention
patients [20]. Aging is, however, related to higher preva-
lence’s of symptoms of depression [11, 18]. Attending
cardiac rehabilitation in the past seems not to affect activity
levels in the long term and might therefore not affect our
findings [4].
We reported higher activity levels in men compared to
women in both the primary and secondary prevention
group. This has also been reported in earlier research [9,
10, 23, 24]. In our study, men and women scored equally
on the PAM, while in previous research it was shown
that women had lower self-efficacy than men [22]. In our
study we found lower scores on the PAM in the primary
prevention group compared to the secondary prevention
group. A positive impact of higher self-regulation and
self-efficacy, proper health status, positive intention,
internal locus of control, and absence of negative illness
beliefs is, for example, are consistently related to exercise
maintenance in CVD population [20, 41] and the non-dis-
ease population [25]. Therefore, we treated the PAM as a
potential confounder in the analysis. And finally, in the
secondary prevention group were more smokers than in
the primary prevention group. Smoking has previously
been reported as inconsistently related to inactivity among
CVD patients [20, 42], but is associated with increased
symptoms of depression levels [19]. Smoking was there-
fore also treated as a potential confounder in the analysis.
Generalizability
Dutch citizens are registered by a GP. The GP has a med-
ical record of almost all patients, and therefore every pa-
tient who is eligible for CVRM within the participating
practices is in the original selection from which the sam-
ple has been taken. Also, the distribution of one third fe-
male and two third male patients is representative of the
CVRM population in the western primary healthcare
facilities. Only 3.8% of the patients had no Dutch national-
ity, and therefore generalizability to people originating
from non-western countries could be limited.
Conclusion
Symptoms of depression are associated with physical in-
activity. This association was not modified by gender
and the presence of a CVD. Future research should
focus on lifestyle interventions aiming at the increase of
physical activity levels while simultaneously improving
symptoms of depression, despite gender difference and
the presence of a CVD. Longitudinal research should be
performed to re-confirm the present findings.
Abbreviations
CVD: Cardiovascular disease; CVRM: Cardiovascular risk management; DSM-
IV: Diagnostic and statistical manual of mental disorders; GP: General
practitioner; ICPC: International classification of primary care; PAM: Patient
activation measure questionnaire; PHQ-9: Patient health questionnaire;
RAPA: Rapid assessment of physical activity questionnaire; RCT: Clustered
randomized clinical trial; STROBE: STrengthening the reporting of
OBservational studies in epidemiology; TICD: Tailored implementation for
chronic diseases
Acknowledgements
We are grateful to Dr. G. Irwin for his statistical advice and English editing.
Funding
None.
Availability of data and materials
The dataset used and/ or analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
RA, MW, JvL, MNvdS, and JBS contributed substantially to the study concept
and research questions. MW and JvL delivered the database. RA, JvL and JBS
analyzed and interpreted the data. The statistical analyses and interpretation
were discussed with the other authors. RA wrote the first concept of the
manuscript. Concept versions of the manuscript were discussed and edited
by JvL, JBS, MNvdS, and MW. All authors read, comment and approved the
final submitted version of the manuscript. All authors agreed both to be
personally accountable for the author’s own contributions and ensure that
questions related to the accuracy or integrity of any part of the work, even
ones in which the author was not personally involved, were appropriately
investigated, resolved, and resolute documented in the literature.
Ethics approval and consent to participate
Data from a previously conducted Randomized clinical trial (RCT) were used.
The Medical Ethics committee Arnhem-Nijmegen, the Netherlands, waived
approval (number 2013/229) for this RCT. All subjects gave written informed
consent. The declaration of Helsinki was followed.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Radboud Institute for Health Sciences, IQ healthcare, Radboud university
medical center, Geert Grooteplein 21, 6500, HB, Nijmegen, The Netherlands.
2Health services research and implementation science in healthcare,
Achttien et al. BMC Cardiovascular Disorders           (2019) 19:95 Page 6 of 7
Heidelberg University, Heidelberg, Germany. 3Research group
Musculoskeletal Rehabilitation, HAN University of Applied Sciences,
Nijmegen, The Netherlands.
Received: 27 April 2018 Accepted: 24 March 2019
References
1. Scrutinio D, Temporelli PL, Passantino A, Giannuzzi P. Long-term secondary
prevention programs after cardiac rehabilitation for the reduction of future
cardiovascular events: focus on regular physical activity. Futur Cardiol. 2009;
5:297–314.
2. Myers J, Prakash M, Froelicher V, Do D, Partingstion S, Atwoord JE. Exercise
capacity and mortality among men referred for exercise testing. N Engl J
Med. 2002;346:793–801.
3. Sunamura M, Ter Hoeve N, van den Berg-Emons HJ, Haverkamp M, Redekop
K, Geleijnse ML, et al. OPTImal CArdiac REhabilitation (OPTICARE) following
acute coronary syndromes: rationale and design of a randomised,
controlled trial to investigate the benefits of expanded educational and
behavioural intervention programs. Neth Heart J. 2013;21:324–30.
4. ter Hoeve N, Huisstede BM, Stam HJ, van Domburg RT, Sunamura M, Van
den berg-Emons RJ. Does cardiac rehabilitation after an acute cardiac
syndrome lead to changes in physical activity habits? Systematic review.
Phys Ther. 2015;95:167–79.
5. Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L, Jennings C, et al.
EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk
factor and therapeutic management of coronary patients from 24 European
countries. Eur J Prev Cardiol. 2016;23:636–48.
6. Cooper AF, Jackson G, Weinman J, Horne R. Factors associated with cardiac
rehabilitation attendance: a systematic review of the literature. Clin Rehabil.
2002;16:541–52.
7. Glazer KM, Emery CF, Frid DJ, Banyasz RE. Psychological predictors of
adherence and outcomes among patients in cardiac rehabilitation. J
Cardpulm Rehabil. 2002;22:40–6.
8. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-
Smith N, et al. Depression as a risk factor for poor prognosis among
patients with acute coronary syndrome: systematic review and
recommendations: a scientific statement from the American Heart
Association. Circulation. 2014;129:1350–69.
9. Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex
differences in cardiovascular risk factors and disease prevention.
Atherosclerosis. 2015;241:211–8.
10. Moller-Leimkuhler AM. Women with coronary artery disease and depression:
a neglected risk group. World J Biol Psychiatry. 2008;9:92–101.
11. Armstrong NM, Meoni LA, Carlson MC, Xue QL, Bandeen-Roche K, Gallo JJ,
et al. Cardiovascular risk factors and risk of incident depression throughout
adulthood among men: the Johns Hopkins precursors study. J Affect Disord.
2017;214:60–6.
12. Hearing CM, Chang WC, Szuhany KL, Deckersbach T, Nierenberg AA, Sylvia
LG. Physical exercise for treatment of mood disorders: a critical review. Curr
Behav Neurosci Rep. 2016;3:350–9.
13. Teychenne M, Ball K, Salmon J. Physical activity and likelihood of depression
in adults: a review. Prev Med. 2008;46:397–411.
14. Schuch FB, Vancampfort D, Firth J, Rosenbaum WFB, Silva ES, et al. Physical
activity and Incedent depression: a meta-analysis of prospective cohort
studies. Am J Psychiatry. 2018;7:631–48.
15. Pogosova GV. Depression-a novel risk factor of ischemic heart disease and
predictor of coronary death. Kardiologiia. 2002;42:86–90.
16. Pelletier R, Bacon SL, Arsenault A, Dupuis J, Laurin C, Blais L, et al. Relative
associations between depression and anxiety on adverse cardiovascular
events: does a history of coronary artery disease matter? A prospective
observational study. BMJ Open. 2015;5:e006582.
17. Rugulies R. Depression as a predictor for coronary heart disease. A review
and meta-analysis. Am J Prev Med. 2002;23:51–61.
18. Paganini-Hill A. Lifestyle practices and cardiovascular disease mortality in
the elderly: the leisure world cohort study. Cardiol Res Pract. 2011:983764.
19. Carroll AJ, Carnethon MR, Liu K, Jacobs DR, Colangelo LA, Stewart JC, et al.
Interaction between smoking and depressive symptoms with subclinical
heart disease in the coronary artery risk development in young adults
(CARDIA) study. Health Psychol. 2017;36:101–11.
20. Petter M, Blanchard C, Kemp KA, Mazoff AS, Ferrier SN. Correlates of exercise
among coronary heart disease patients: review, implications and future
directions. Eur J Cardiovasc Prev Rehabil. 2009;16:515–26.
21. Moller-Leimkuhler AM. Gender differences in cardiovascular disease and
comorbid depression. Dialogues Clin Neurosci. 2007;9:71–83.
22. Blanchard C, Arthur HM, Gunn E. Self-efficacy and outcome expectations in
cardiac rehabilitation: associations with women's physical activity. Rehabil
Psychol. 2015;60:59–66.
23. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al.
Evidence-based guidelines for cardiovascular disease prevention in women:
2007 update. J Am Coll Cardiol. 2007;49:1230–50.
24. Trost SG, Owen N, Bauman AE, Sallis JF, Brown W. Correlates of adults'
participation in physical activity: review and update. Med Sci Sports Exerc.
2002;34:1996–2001.
25. Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW. Correlates of
physical activity: why are some people physically active and others not?
Lancet. 2012;380:258–71.
26. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al.
Prevalence of depression in survivors of acute myocardial infarction. J Gen
Intern Med. 2006;21:30–8.
27. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P.
Prognostic association of depression following myocardial infarction with
mortality and cardiovascular events: a meta-analysis of 25 years of research.
Gen Hosp Psychiatry. 2011;33:203–16.
28. van Lieshout J, Huntink E, Koetsenruijter J, Wensing M. Tailored
implementation of cardiovascular risk management in general practice: a
cluster randomized trial. Implement Sci. 2016;11:115.
29. Wensing M. The tailored implementation in chronic diseases (TICD) project:
introduction and main findings. Implement Sci. 2017;12:5.
30. Huntink E, Heijmans N, Wensing M, van Lieshout J. Effectiveness of a
tailored intervention to improve cardiovascular risk management in primary
care: study protocol for a randomised controlled trial. Trials. 2013;14:433.
31. STROBE initiative group Strobe-statement. 2009. https://www.strobe-
statement.org/index.php?id=strobe-home. Accessed 10 Jan 2018.
32. Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The
rapid assessment of physical activity (RAPA) among older adults. Prev
Chronic Dis. 2006;3:A118.
33. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression
severity measure. J Gen Intern Med. 2001;16:606–13.
34. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient
activation measure (PAM): conceptualizing and measuring activation in
patients and consumers. Health Serv Res. 2004;35:1005–26.36.
35. Mayer CJ, Steinman L, Williams B, Topolski TD, LoGerfo J. Developing a
telephone assessment of physical activity (TAPA) questionnaire for older
adults. Prev Chronic Dis. 2008;5:A24.
36. Yaroch AL, Nebeling L, Thompson FE, Hurley TG, Hebert JR, Toobert DJ, et
al. Baseline design elements and sample characteristics for seven sites
participating in the nutrition working Group of the Behavior Change
Consortium. J Nutr. 2008;138:185S–92S.
37. Lani J. Statistics solutions. 2018. http://www.statisticssolutions.com/.
Accessed 10 Jan 2018.
38. Vancampfort D, Stubbs B, Veronese N, Mugisha N, Koyanagi A. Correlates of
physical activity among depressed older people in six low-income and
middle income countries: Acommunity-bases cross-sectional study. Int J
Geriatr Psychiatry. 2018;2:314–22.
39. Vancampfort D, Stubbs B, Sienaert P, Wyckaert S, Hert D, Rosenbaum S,
Probst M. What are the factors that influence physical activity participation
in individuals with depression? A review of physical activity correlater from
59 studies. Psychiatr Danub. 2015;3:210–24.
40. Blanchard CM, Reid RD, Morrin LI, McDonnell L, McGannon K, Rhodes RE, et
al. Demographic and clinical determinants of moderate to vigorous physical
activity during home-based cardiac rehabilitation: the home-based
determinants of exercise (HOME) study. J Cardiopulm Rehabil Prev. 2010;30:
240–5.
41. Sallis JF, Prochaska JJ, Taylor WC. A review of correlates of physical activity
of children and adolescents. Med Sci Sports Exerc. 2000;32:963–75.
42. Gaalema DE, Savage PD, Rengo JL, Cutler AY, Elliott RJ, Priest JS, et al.
Patient characteristics predictive of cardiac rehabilitation adherence. J
Cardiopulm Rehabil Prev. 2017;37:103–10.
Achttien et al. BMC Cardiovascular Disorders           (2019) 19:95 Page 7 of 7
